Treatment of diseases mediated by vascular hyperpermeability
AssigneeAmpio Pharmaceuticals, Inc.
InventorsDavid BAR-OR, Gregory THOMAS
Life of this patent
Estimating the term…
Abstract
The invention provides a method of inhibiting vascular hyperpermeability in an animal in need thereof. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a human serum albumin composition and one or more p38 MAPK inhibitors to the animal.
Claims29
A method of inhibiting vascular hyperpermeability in an animal in need thereof comprising administering to the animal an effective amount of
- (i) a pharmaceutical composition prepared by removing albumin from a human serum albumin composition;
- and
- (ii) one or more p38 MAPK inhibitors.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising a composition prepared by removing albumin from a human serum albumin composition and one or more p38 MAPK inhibitors for the treatment of a disease or condition mediated by vascular hyperpermeability and/or for the inhibition of vascular hyperpermeability.
Dependencies are inferred from the claim text.